Life Biosciences — Full Portfolio
3 tracked investments · listed companies and verified rows first
Life Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs.
BiotechHealthtechLongevityBoston, US
David Sinclair(Director)inSharon Rosenzweig-Lipson(Chief Scientific Officer)inMichael Ringel(Chief Operating Officer)inAmit Shashank(Chief Administrative Officer & General Counsel)inAlexander Tristan Edwards(Executive Officer)Mehmood Khan(Executive Officer)in
Board seatDavid SinclairAdam NeumannBracken Darrell· per SEC Form D · $31M raise · filed Apr 2026
Co-investorsAlpha Wave GlobalGaingelsPHD VenturesThe Venture CollectiveW venturesW Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






__Twitter.png)
